| Year |
Citation |
Score |
| 2012 |
Johnson EO, Chang KH, Ghosh S, Venkatesh C, Giger K, Low PS, Shah K. LIMK2 is a crucial regulator and effector of Aurora-A-kinase-mediated malignancy. Journal of Cell Science. 125: 1204-16. PMID 22492986 DOI: 10.1242/Jcs.092304 |
0.621 |
|
| 2011 |
Johnson EO, Chang KH, de Pablo Y, Ghosh S, Mehta R, Badve S, Shah K. PHLDA1 is a crucial negative regulator and effector of Aurora A kinase in breast cancer. Journal of Cell Science. 124: 2711-22. PMID 21807936 DOI: 10.1242/Jcs.084970 |
0.611 |
|
| 2010 |
Kumar D, Kumar NM, Sundaree S, Johnson EO, Shah K. An expeditious synthesis and anticancer activity of novel 4-(3'-indolyl)oxazoles. European Journal of Medicinal Chemistry. 45: 1244-9. PMID 20047778 DOI: 10.1016/J.Ejmech.2009.12.024 |
0.504 |
|
| 2009 |
Kumar D, Sundaree S, Johnson EO, Shah K. An efficient synthesis and biological study of novel indolyl-1,3,4-oxadiazoles as potent anticancer agents. Bioorganic & Medicinal Chemistry Letters. 19: 4492-4. PMID 19559607 DOI: 10.1016/J.Bmcl.2009.03.172 |
0.497 |
|
| 2009 |
Kumar D, Patel G, Johnson EO, Shah K. Synthesis and anticancer activities of novel 3,5-disubstituted-1,2,4-oxadiazoles. Bioorganic & Medicinal Chemistry Letters. 19: 2739-41. PMID 19376704 DOI: 10.1016/J.Bmcl.2009.03.158 |
0.497 |
|
| 2008 |
Sun KH, de Pablo Y, Vincent F, Johnson EO, Chavers AK, Shah K. Novel genetic tools reveal Cdk5's major role in Golgi fragmentation in Alzheimer's disease. Molecular Biology of the Cell. 19: 3052-69. PMID 18480410 DOI: 10.1091/Mbc.E07-11-1106 |
0.604 |
|
| 2007 |
Vincent F, Cook SP, Johnson EO, Emmert D, Shah K. Engineering unnatural nucleotide specificity to probe G protein signaling. Chemistry & Biology. 14: 1007-18. PMID 17884633 DOI: 10.1016/J.Chembiol.2007.08.006 |
0.452 |
|
| Show low-probability matches. |